Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer - Paola Cappello; Maurizio Martini; Aldo Scarpa; Stefano Ugel; Francesco De Sanctis; Giampaolo Tortora; Emilio Bria; Vincenzo Corbo; Carmine Carbone; Geny Piro; Antonio Agostini; Pietro Delfino; et al. (Journal for ImmunoTherapy of Cancer, 2021)